Produktname:4-bromo-5-(cyclopropylmethyl)-1-methyl-1H-pyrazole
IUPAC Name:4-bromo-5-(cyclopropylmethyl)-1-methyl-1H-pyrazole
- CAS:2079069-45-5
- Molekulare Formel:C8H11BrN2
- Reinheit:95%+
- Katalognummer:CM423884
- Molekulargewicht:215.09
Packungseinheit |
Verfügbarer Vorrat |
Preis($) |
Menge |
CM423884-100mg |
3-4 Weeks |
-- |
|
CM423884-250mg |
3-4 Weeks |
-- |
|
CM423884-1g |
4-5 Weeks |
-- |
|
CM423884-5g |
6-7 Weeks |
-- |
|
|
|
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:2079069-45-5
- Molekulare Formel:C8H11BrN2
- Schmelzpunkt:-
- SMILES-Code:CN1N=CC(Br)=C1CC1CC1
- Dichte:
- Katalognummer:CM423884
- Molekulargewicht:215.09
- Siedepunkt:
- Mdl-Nr.:MFCD31652575
- Lagerung:
Category Infos
- Pyrazoles
- Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
- Pyrazone
- Custom pyrazone for customers from all over the world are our main business.
Column Infos
- BTX-A51
- Edgewood Oncology announced that the first two patients with metastatic breast cancer were treated with BTX-A51, a multi-specific kinase inhibitor of casein kinase 1 alpha (CK1α) and cyclin-dependent kinases 7 and 9 (CDK7 and CDK9), that synergistically targets master regulators of cancer. BTX-A51 is being evaluated in a Phase 2a study for the treatment of estrogen receptor positive / human epidermal growth factor receptor 2 negative (ER+/HER2-) metastatic breast cancer with and without GATA binding protein 3 (GATA3) mutations.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.